Dernières nouvelles pour Critical Metals (NASDAQ:CRML) Stock

Critical Metals Corp is engaged in lithium exploration in Austria. It is focused on the development of its wholly-owned Wolfsberg Lithium Project (the Wolfsberg Project) located in Carinthia, Austria.

Critical Metals Corp

CHINA MX LFESTYL UNSP/ADR by CHINA RES MIXC LIFESTYLE SVCS LTD.

China Resources Mixc Lifestyle Services Ltd

Jefferies analyst Omar Nokta maintains Teekay Tankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNK#NYSE">TNK</a>) with a Buy and maintains $55 price target.

News

Price Target

Analyst Ratings

Jefferies Maintains Buy on Teekay Tankers, Maintains $55 Price Target

Needham analyst Ryan Koontz maintains F5 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) with a Buy and raises the price target from $320 to $345.

FFIV

Needham Maintains Buy on F5, Raises Price Target to $345

Ferrari (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RACE#NYSE">RACE</a>) reported quarterly earnings of $2.70 per share which beat the analyst consensus estimate of $2.39 by 13.08 percent. This is a 9.23 percent increase over earnings of $2.47 per share from the same period last year. The company reported quarterly sales of $2.03 billion which beat the analyst consensus estimate of $1.82 billion by 11.13 percent. This is a 9.93 percent increase over sales of $1.84 billion the same period last year.

Earnings

Earnings Beats

RACE

Ferrari Q2 EPS $2.70 Beats $2.39 Estimate, Sales $2.03B Beat $1.82B Estimate

<ul>
<li>Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8% lower rate of MACE-3 events, while delivering greater reductions in A1C and weight</li>
<li>In the trial, Mounjaro was associated with a 16% lower rate of all-cause death compared to Trulicity, suggesting more comprehensive health benefits</li>
<li>Results from the largest and longest Mounjaro trial to date reaffirm its established safety and tolerability profile</li>
</ul>

Biotech

Large Cap

Health Care

General

Eli Lilly Announced Topline Results From SURPASS-CVOT Head-to-head Phase 3 Trial Comparing Mounjaro (Tirzepatide) To Trulicity (Dulaglutide), Mounjaro Achieved The Primary Objective By Demonstrating A Non-inferior Rate Of Major Adverse Cardiovascular Events, Including Cardiovascular Death, Heart Attack Or Stroke Vs. Trulicity

Needham analyst Ryan MacDonald reiterates Udemy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UDMY#NASDAQ">UDMY</a>) with a Buy and maintains $11 price target.

Reiteration

UDMY

Needham Reiterates Buy on Udemy, Maintains $11 Price Target

Guidance

APTV

Aptiv Raises FY2025 Adj EPS Guidance from $7.00-$7.60 to $7.30-$7.60 vs $7.14 Est; Narrows FY2025 Sales Guidance from $19.600B-$20.400B to $20.000B-$20.300B vs $19.691B Est

Gildan Activewear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIL#NYSE">GIL</a>) narrows FY2025 Adj EPS guidance from $3.38-$3.58 to $3.40-$3.56 vs $3.48 analyst estimate..

Gildan Activewear Narrows FY2025 Adj EPS Guidance from $3.38-$3.58 to $3.40-$3.56 vs $3.48 Est

Canada Goose Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOOS#NYSE">GOOS</a>) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.62) by 6.45 percent. This is a 14.19 percent decrease over losses of $(0.58) per share from the same period last year. The company reported quarterly sales of $77.879 million which beat the analyst consensus estimate of $68.330 million by 13.97 percent. This is a 20.94 percent increase over sales of $64.397 million the same period last year.

Earnings Misses

GOOS

Canada Goose Hldgs Q1 Adj. EPS $(0.66) Misses $(0.62) Estimate, Sales $77.879M Beat $68.330M Estimate

Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) is looking for Q3 Adj EPS of $1.60-$1.80 vs $1.81 analyst estimate. sees sales of $4.950 billion-$5.100 billion vs $4.928 billion analyst estimate.

Aptiv Sees Q3 Adj EPS $1.60-$1.80 vs $1.81 Est; Sees Sales $4.950B-$5.100B vs $4.928B Est

CSW Industrials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSW#NYSE">CSW</a>) reported quarterly earnings of $2.43 per share which missed the analyst consensus estimate of $2.76 by 11.86 percent. This is a 1.62 percent decrease over earnings of $2.47 per share from the same period last year. The company reported quarterly sales of $263.646 million which missed the analyst consensus estimate of $278.060 million by 5.18 percent. This is a 16.57 percent increase over sales of $226.177 million the same period last year.

CSW Industrials Q1 EPS $2.43 Misses $2.76 Estimate, Sales $263.646M Miss $278.060M Estimate

Utz Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTZ#NYSE">UTZ</a>) lowers FY2025 Adj EPS guidance from $0.85-$0.89 to $0.82-$0.85 vs $0.85 analyst estimate..

Utz Brands Lowers FY2025 Adj EPS Guidance from $0.85-$0.89 to $0.82-$0.85 vs $0.85 Est

XPO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $1.00 by 5 percent. This is a 6.25 percent decrease over earnings of $1.12 per share from the same period last year. The company reported quarterly sales of $2.08 billion which beat the analyst consensus estimate of $2.06 billion by 1.13 percent. This is a 0.05 percent increase over sales of $2.08 billion the same period last year.

XPO Q2 Adj. EPS $1.05 Beats $1.00 Estimate, Sales $2.08B Beat $2.06B Estimate

Gildan Activewear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIL#NYSE">GIL</a>) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.95 by 1.57 percent. This is a 31.08 percent increase over earnings of $0.74 per share from the same period last year. The company reported quarterly sales of $918.500 million which beat the analyst consensus estimate of $911.417 million by 0.78 percent. This is a 6.53 percent increase over sales of $862.200 million the same period last year.

Gildan Activewear Q2 Adj. EPS $0.97 Beats $0.95 Estimate, Sales $918.500M Beat $911.417M Estimate

Needham analyst Bernie McTernan maintains Fiverr Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FVRR#NYSE">FVRR</a>) with a Buy and lowers the price target from $36 to $32.

FVRR

Needham Maintains Buy on Fiverr Intl, Lowers Price Target to $32

Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) reported quarterly earnings of $2.12 per share which beat the analyst consensus estimate of $1.79 by 18.57 percent. This is a 34.18 percent increase over earnings of $1.58 per share from the same period last year. The company reported quarterly sales of $5.208 billion which beat the analyst consensus estimate of $5.032 billion by 3.51 percent. This is a 3.11 percent increase over sales of $5.051 billion the same period last year.

Aptiv Q2 Adj. EPS $2.12 Beats $1.79 Estimate, Sales $5.208B Beat $5.032B Estimate

Telsey Advisory Group analyst Joseph Feldman maintains Traeger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COOK#NYSE">COOK</a>) with a Market Perform and maintains $2 price target.

COOK

Telsey Advisory Group Maintains Market Perform on Traeger, Maintains $2 Price Target

Xerox Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRX#NASDAQ">XRX</a>) sees FY2025 sales of $7.240 billion-$7.360 billion vs $6.209 billion analyst estimate.

Xerox Holdings Sees FY2025 Sales $7.240B-$7.360B vs $6.209B Est

Telsey Advisory Group analyst Dana Telsey maintains VF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) with a Market Perform and maintains $14 price target.

Telsey Advisory Group Maintains Market Perform on VF, Maintains $14 Price Target

MAC Copper Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTAL#NYSE">MTAL</a>, ASX:MAC))) ("MAC" or the "Company") is pleased to announce that the Royal Court of Jersey ("Court") today ordered that meetings of MAC shareholders be held to consider the proposed acquisition of 100% of the issued share capital in MAC by Harmony Gold (Australia) Pty Ltd ("Harmony Australia") (a wholly owned subsidiary of Harmony Gold Mining Company Limited (JSE:HAR, NYSE:HMY) ("Harmony")) by way of a Jersey law scheme of arrangement pursuant to Article 125 of the Companies (Jersey) Law 1991 ("Scheme") (the "Transaction").
Unless otherwise defined, capitalised terms used in this announcement have the meaning given to them in the Scheme Circular (as defined below).
Court orders
The Court has today made orders, among other things, that MAC:
<ul>
<li>convene a meeting of Scheme Shareholders to consider and vote on a resolution to approve the Scheme ("Court Meeting"); and</li>
<li>convene a meeting of MAC Shareholders immediately after the Court Meeting to approve certain other matters in connection with the implementation of the Transaction ("General Meeting").</li>
</ul>
The MAC Directors:
<ul>
<li>continue to unanimously recommend that Scheme Shareholders vote in favour of the Scheme at the Court Meeting and MAC Shareholders vote in favour of the General Meeting Resolution at the General Meeting; and</li>
<li>intend to vote, or cause to be voted, all MAC Shares or MAC CDIs held or controlled by them (totalling 2.44% of the MAC Shares in aggregate) in favour of the Scheme at the Court Meeting and in favour of the General Meeting Resolution at the General Meeting, in each case, in the absence of a Superior Proposal.</li>
</ul>
Scheme Circular
The Court approved the dispatch of a scheme circular, which, among other things, contains full details of the Scheme (the "Scheme Circular"). Dispatch of the Scheme Circular to MAC Shareholders and MAC CDI Holders at the Scheme Voting Record Time is expected to be completed on or about 4 August 2025 as follows:
<ul>
<li>MAC Shareholders will receive a hard copy of the Scheme Circular and Proxy Forms by mail unless they have made an election to receive communications through electronic means, in which case they will receive an electronic copy;</li>
<li>MAC CDI Holders will receive a hard copy of the Scheme Circular and CDI Voting Instruction Forms by mail unless they have made an election to receive communications through electronic means, in which case they will receive an electronic copy; and</li>
<li>other beneficial holders will receive a hard copy of the Scheme Circular and any other voting instruction forms by mail or an electronic copy based on the elections made with the Intermediary that holds MAC Shares on their behalf.</li>
</ul>
A copy of the Scheme Circular is attached to this announcement and is also available for viewing on MAC's website at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.maccopperlimited.com&amp;esheet=54300052&amp;newsitemid=20250730628270&amp;lan=en-US&amp;anchor=www.maccopperlimited.com&amp;index=1&amp;md5=ddd82b68e80f5b0378d8cbdcc0c5efa5">www.maccopperlimited.com</a>.
MAC Securityholders should read the Scheme Circular carefully, and in its entirety, including the materials accompanying it, before deciding how to vote at the Court Meeting and the General Meeting.
If, after reading the Scheme Circular, you have any questions about the Scheme or the Scheme Circular, please contact MAC's proxy solicitation firm, Sodali &amp; Co, at:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">If you are a MAC Shareholder Call toll-free in US: +1 (800) 662-5200 Outside of US: +1 (203) 658-9400</td>
<td colspan="1" rowspan="1">If you are a MAC CDI Holder Within Australia: 1300 229 418 Outside Australia: +61 2 9066 4059</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;

Legal

MTAL

MAC Copper Moves Closer to Harmony Gold Deal After Jersey Court Approves Shareholder Meetings

TC Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TRP#TSX">TRP</a>) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.70 by 17.14 percent. This is a 3.8 percent increase over earnings of $0.79 per share from the same period last year. The company reported quarterly sales of $3.744 billion which beat the analyst consensus estimate of $3.152 billion by 18.78 percent. This is a 8.35 percent decrease over sales of $4.085 billion the same period last year.

TSX:TRP

TC Energy Q2 Adj. EPS $0.82 Beats $0.70 Estimate, Sales $3.744B Beat $3.152B Estimate

Press Releases

Critical Metals Corp.'s Tanbreez Valued at $3 Billion With IRR of 180% and Significant Additional Upside Potential

Critical Metals Corp. Publishes New Presentation on Investor Website

Management

Critical Metals Corp Announces Appointments of Executive Leaders

Critical Metals Corp Publishes Compelling Deep Diamond Drill Results from Tanbreez Greenland

Critical Metals Corp Releases Further Excellent Deep High-Grade Drilling Results on Tanbreez (TREO 0.48% & HREO 27%)

Critical Metals Corp Announces Gross Proceeds of $2MM USD from the Exercise of Warrants Priced at $5.00 USD from Institutional Fund

Critical Metals Corp Releases Additional High-Grade REE Results From Diamond Drilling at Tanbreez in Greenland

Critical Metals Corp Secures US$120,000,000 LOI for a 15-Year Term Loan From the US Federal Government Bank (EXIM Bank) for the Development of its Tanbreez Rare Earth Project in Greenland

Contracts

Critical Metals Corp Signs Infill Diamond Drilling Program to Significantly Increase the Size of the Resource at Tanbreez

Critical Metals Corp Targets Significantly Increased Resource Upgrade on 500MT Exploration Target within 4.7BT TREO

CRML

American Battery Technology Company - Common Stock

American Battery Tech

BHP Group Limited American Depositary Shares (Each representing two Ordinary Shares)

Comments

Critical Metals

Actualités

Dernières nouvelles pour Critical Metals (NASDAQ:CRML) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL